FACS Aria II for Flow Cytometry Core Facility
FACS Aria II for Flow Cytometry Core Facility
批准号:
7794292
负责人:
Teresa Liberati
金额:
$47.29万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-15 至 2011-04-14
关键词:
AreaCell SeparationCellsCollectionCommunicable DiseasesCore FacilityData CollectionDevelopmentFacultyFlow CytometryFundingGrantIllinoisInvestmentsMalignant NeoplasmsNational Center for Research ResourcesNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseasePathologic ProcessesPopulationPopulation HeterogeneityProcessProductivityResearchResearch PersonnelResolutionSorting - Cell MovementSourceSystemTechnologyTherapeutic EffectUnited States National Institutes of HealthUniversitiesVendorcell typeinstrumentationinterestmedical schoolsmeetingsmembertool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Southern Illinois University School of Medicine requests support to purchase a new flow cytometer for our core lab. The requested BD FACSAria II will replace a FACSVantage that was purchased with a Shared Instrumentation Grant in 1993 and remains in use today as our only cell sorter, documenting an incredible return-on-investment for NCRR. However, this unit is quite outdated and no longer meets the research needs of our faculty. Furthermore, after 2009 the Vantage will no longer be supported by the vendor. The FACSAria II will support a core of 7 NIH-funded faculty members with diverse research interests, as indicated by their varied sources of NIH funding (NCI, NHLBI, and NIAID). FACSAria II technology will effectively increase the quality of their data collection, their available research options, and their overall productivity. The ability to obtain high-quality populations of sorted cells will contribute to more rapid advances in our understanding of the causes and course of cancer, infectious diseases, cell development, and other aspects of cellular and biomolecular processes. Because the FACSAria II allows rapid, reliable cell sorting, it reduces the cell loss and variability inherent in older systems. By increasing the temporal and spatial resolution of the sorting, the technology allows collection of specific but rare cell types from a heterogeneous population, thereby supporting precise and accurate characterization of therapeutic effects and normal versus pathological processes. These benefits will allow our NIH- funded and other investigators to advance their respective research areas in ways not otherwise possible with the tools currently available to them at SIUSM.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis.
支持人类红细胞生成过程中 Fas 反义长非编码 RNA 的转录调控和功能的数据。
DOI:
10.1016/j.dib.2016.03.106
发表时间:
2016
期刊:
Data in brief
影响因子:
1.2
作者:
[Villamizar,Olga, Chambers,ChristopherB, Mo,Yin-Yuan, Torry,DonaldS, Hofstrand,Reese, Riberdy,JaniceM, Persons,DerekA, Wilber,Andrew]
通讯作者:
Wilber,Andrew
DOI:
10.1371/journal.pone.0122253
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Chambers CB, Halford WP, Geltz J, Villamizar O, Gross J, Embalabala A, Gershburg E, Wilber A]
通讯作者:
Wilber A
DOI:
10.1016/j.bcmd.2016.03.002
发表时间:
2016-05
期刊:
Blood cells, molecules & diseases
影响因子:
--
作者:
[Olga Villamizar;C. Chambers;Y. Mo;D. Torry;R. Hofstrand;J. Riberdy;D. Persons;A. Wilber]
通讯作者:
Olga Villamizar;C. Chambers;Y. Mo;D. Torry;R. Hofstrand;J. Riberdy;D. Persons;A. Wilber
DOI:
10.18632/oncotarget.7329
发表时间:
2016-03-22
期刊:
Oncotarget
影响因子:
--
作者:
[Villamizar O, Chambers CB, Riberdy JM, Persons DA, Wilber A]
通讯作者:
Wilber A
Leica TCS SP5 Spectral LSCM for the Research Imaging Facility
-
批准号:7793952
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:Teresa Liberati
-
依托单位:
海外基金